Swiss National Bank
TXMD icon

Swiss National Bank’s TherapeuticsMD TXMD Stock Holding History

Swiss National Bank’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,744
Closed -$621K – 2748
2021
Q3 		$621K Hold
16,744
– – ﹤0.01% 2552
2021
Q2 		$996K Hold
16,744
– – ﹤0.01% 2484
2021
Q1 		$1.12M Buy
16,744
+5,600
+50% +$438K ﹤0.01% 2308
2020
Q4 		$674K Hold
11,144
– – ﹤0.01% 2418
2020
Q3 		$880K Hold
11,144
– – ﹤0.01% 2154
2020
Q2 		$697K Buy
11,144
+1,678
+18% +$97.7K ﹤0.01% 2288
2020
Q1 		$502K Buy
9,466
+258
+3% +$25.6K ﹤0.01% 2174
2019
Q4 		$1.11M Buy
9,208
+1,580
+21% +$227K ﹤0.01% 2083
2019
Q3 		$1.39M Hold
7,628
– – ﹤0.01% 1878
2019
Q2 		$1M Buy
7,628
+258
+4% +$46.3K ﹤0.01% 2109
2019
Q1 		$1.8M Buy
7,370
+350
+5% +$92.6K ﹤0.01% 1730
2018
Q4 		$1.34M Buy
7,020
+614
+10% +$150K ﹤0.01% 1822
2018
Q3 		$2.1M Hold
6,406
– – ﹤0.01% 1691
2018
Q2 		$2M Buy
6,406
+378
+6% +$115K ﹤0.01% 1716
2018
Q1 		$1.47M Buy
6,028
+232
+4% +$65.1K ﹤0.01% 1845
2017
Q4 		$1.75M Hold
5,796
– – ﹤0.01% 1726
2017
Q3 		$1.53M Buy
5,796
+636
+12% +$184K ﹤0.01% 1803
2017
Q2 		$1.36M Hold
5,160
– – ﹤0.01% 1837
2017
Q1 		$1.86M Hold
5,160
– – ﹤0.01% 1613
2016
Q4 		$1.49M Hold
5,160
– – ﹤0.01% 1774
2016
Q3 		$1.76M Sell
5,160
-190
-4% -$69.4K ﹤0.01% 1597
2016
Q2 		$2.27M Buy
5,350
+162
+3% +$66.8K ﹤0.01% 1417
2016
Q1 		$1.6M Buy
5,188
+1,644
+46% +$561K ﹤0.01% 1580
2015
Q4 		$1.84M Hold
3,544
– – ﹤0.01% 1400
2015
Q3 		$1.04M Buy
3,544
+898
+34% +$319K ﹤0.01% 1760
2015
Q2 		$1.04M Buy
+2,646
New +$934K ﹤0.01% 1777

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank's TXMD Position: Q4 2021 in Review

Swiss National Bank sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 16,744 shares — an estimated $621K sold.

Swiss National Bank first reported a position in TXMD in Q2 2015 and held it in 26 quarters. The position peaked at $2.27M in Q2 2016. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Swiss National Bank reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Swiss National Bank sold 16,744 TherapeuticsMD shares in Q4 2021, an estimated $621K.
  • Swiss National Bank first reported a position in TherapeuticsMD in Q2 2015 and held it in 26 quarters.
  • Swiss National Bank's TherapeuticsMD position peaked at $2.27M in Q2 2016.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Swiss National Bank's 13F filing for Q4 2021, filed 8 Feb 2022.